KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Vir Biotechnology (VIR) over the last 5 years, with Q3 2025 value amounting to $138.9 million.

  • Vir Biotechnology's Shares Outstanding (Diluted Average) rose 166.58% to $138.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.9 million, marking a year-over-year increase of 166.58%. This contributed to the annual value of $136.2 million for FY2024, which is 157.75% up from last year.
  • Latest data reveals that Vir Biotechnology reported Shares Outstanding (Diluted Average) of $138.9 million as of Q3 2025, which was up 166.58% from $138.4 million recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Shares Outstanding (Diluted Average) registered a high of $138.9 million during Q3 2025, and its lowest value of $133.4 million during Q4 2021.
  • For the 5-year period, Vir Biotechnology's Shares Outstanding (Diluted Average) averaged around $135.5 million, with its median value being $135.0 million (2022).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first tumbled by 50.44% in 2023, then soared by 176.05% in 2024.
  • Over the past 5 years, Vir Biotechnology's Shares Outstanding (Diluted Average) (Quarter) stood at $133.4 million in 2021, then increased by 1.03% to $134.8 million in 2022, then fell by 0.5% to $134.1 million in 2023, then increased by 1.58% to $136.2 million in 2024, then grew by 1.97% to $138.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $138.9 million for Q3 2025, versus $138.4 million for Q2 2025 and $137.5 million for Q1 2025.